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Abstract 
 
Recent Clinical research focused mainly on the therapeutic safety which mainly involves 
the avoidance of toxicities. To prevent the toxicities, site targeted drugs are improved which 
exhibit their therapeutic action on the specific target or the diseased target without disturbing the 
healthy  cells.  Folic  acid,  a  natural  Vitamin  (Vit  B9)  has  shown  promising  results  in  site 
specificity mainly in the cancer cells where they are abundantly present. 
Folic acid is of great importance because of the promising results of several clinical trials 
which demonstrate that Folic acid increases the potency and simultaneously reducing the toxicity 
of the cancer therapies. Various different forms of drugs attached to the Folate for the target 
delivery are protein toxins, chemotherapeutic agents, oligonucleotides, liposomes with entrapped 
drugs, radiotherapeutic agents, immunotherapeutic agents, genetherapy vectors, MRI contrast 
agents and enzyme constructs for prodrug therapy.   Recent clinical studies reveal that studies 
on coating of folate on surfaces such as gold surfaces  and nanoparticles further increased the 
scope of use of Folate as a site specific target delivery system.    Folic acid used as a folate 
binding protein or the folate receptor is used to target the diseased cell. The Folate receptor FR-α 
is used as a receptor to carry the folate into the cells. For the Folate based drug delivery systems, 
the concentration of the folic acid on the protein or the drug also acts as a variable for the 
transport of the drug, less concentration of the folic acid on the protein or drug may result in the 
poor binding of the drug or the protein to be transported to the folate where as a very high 
concentration of the folic acid may not bind to the protein or the drug as the formation of 
precipitates are evident. Therefore to avoid the overlabeling or underlabeling, optimal 
concentrations are to be designed for proper efficiency of the drug delivery to the target site. 
Recent research limited on a single concentration of the folate which is bound to the protein for 
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the target delivery. Our project mainly focused on the maximum labeling of the folate onto the 
protein to provide the best results for the target delivery. The labeling was carried out using the 
Human Bovine Serum Albumin as the protein and the EDC as the linker to bind the Folic acid on 
the protein. 
 
 
 
